News Page Banner


Perry Dellelce Appointed as Chair of Board of Directors of Mind Medicine (MindMed) Inc.

Tuesday, February 2, 2021

Perry Dellelce has been appointed as Chair of the board of directors of Mind Medicine (MindMed) Inc., a leading psychedelic medicine biotech company.

Mind Medicine (MindMed) Inc. streamlined its leadership team to further develop the company's strategy of integrating its psychedelic clinical development programs with innovative digital technologies.

To read the full press release, click here.

For more information on the firm or to find out more about the services of Wildeboer Dellelce LLP, please visit or email  

Follow us on Twitter and LinkedIn.